UPDATE 1-Teva Pharm to buy Mexican drugmaker Rimsa for $2.3 bln

TEL AVIV, Oct 1 (Reuters) - Teva Pharmaceutical Industries has struck a deal to buy Mexican drugmaker Representaciones e Investigaciones Médicas SA (Rimsa) for $2.3 billion to strengthen its presence in Latin America.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.